Systemic lupus erythematosus

A8.05 Mirnas expression in systemic lupus erythematosus
R Shumnalieva, D Kachakova, S Monov, R Kaneva, Zl Kolarov, R Rashkov

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A66-A67; DOI: 10.1136/annrheumdis-2016-209124.158
A8.07 Characterising effects of epigenetic regulation in assays using peripheral blood mononuclear cells from patients with inflammatory diseases
O Aftab, Y Sundström, F Bergqvist, K Kultima, MG Gustafsson, R Larsson, M Sundström, E Ossipova, J Lengqvist, PJ Jakobsson, J Rubin, L Berg

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A67; DOI: 10.1136/annrheumdis-2016-209124.160
A9.06 Analysis of cell-specific interferon response in systemic lupus erythematosus using a novel flow cytometric assay
YM El-Sherbiny, MY Md Yusof, EM Hensor, A Psarras, A Mohamed, M Wittmann, P Emery, EM Vital

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A72; DOI: 10.1136/annrheumdis-2016-209124.172
A9.05 Distinct subsets of interferon-stimulated genes are associated with incomplete and established systemic lupus erythematosus
A Psarras, MY Md Yusof, YM El-Sherbiny, EM Hensor, M Wittmann, P Emery, EM Vital

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A72; DOI: 10.1136/annrheumdis-2016-209124.171
A5.07 The role of immunologic and inflammatory factors in the risk of microvascular and macrovascular impairment development in systemic lupus erythematosus – preliminary data
K Fischer, M Sawicki, K Chamiak-Ciemińska, J Stolarczyk, A Winikajtis-Burzyńska, M Milchert, L Ostanek, D Bobrowska-Snarska, Ł Kapłon, H Przepiera-Będzak, A Walecka, I Brzosko, M Brzosko

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A44; DOI: 10.1136/annrheumdis-2016-209124.105
A6.08 Transcriptome profiling by next generation sequencing of hematopoietic progenitors in murine systemic lupus erythematosus (SLE)
A Banos, M Grigoriou, P Verginis, P Pavlidis, G Bertsias, DT Boumpas

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A50; DOI: 10.1136/annrheumdis-2016-209124.120
A6.12 Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
TD de Jong, S Vosslamber, E Mantel, S de Ridder, JG Wesseling, TCTM van der Pouw Kraan, C Leurs, H Hegen, F Deisenhammer, J Killestein, IE Lundberg, J Vencovsky, MT Nurmohamed, D van Schaardenburg, IEM Bultink, AE Voskuyl, DM Pegtel, CJ van der Laken, JW Bijlsma, CL Verweij

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A52; DOI: 10.1136/annrheumdis-2016-209124.124
A6.14 Dysregulations in the sphingolipid pathway in sle patients
A Checa, H Idborg, D Garcia Sar, PJ Jakobsson, CE Wheelock, I Gunnarsson

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A53; DOI: 10.1136/annrheumdis-2016-209124.126
A6.15 Characterisation of systemic lupus erythematosus subgroups with features of antiphospholipid or sjögrens´s syndrome utilising affinity proteomics
H Idborg, A Zandian, JT Gustafsson, I Gunnarsson, E Svenungsson, P Nilsson, PJ Jakobsson

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A53; DOI: 10.1136/annrheumdis-2016-209124.127
A6.17 FCGR2A association with susceptibility to autoimmune and inflammatory diseases
JI Robinson, JC Taylor, E Foy, T Vyse, R Cooper, H Chinoy, J Lamb, A Barton, J Martin, AH Sawalha, AG Wilson, JH Barrett, AW Morgan

Annals of the Rheumatic Diseases Feb 2016, 75 (Suppl 1) A54-A55; DOI: 10.1136/annrheumdis-2016-209124.129

Main menu

Systemic lupus erythematosus

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic lupus erythematosus

Pages